Category Archives: Endocrinology

What we’ve all been waiting for: Third amended complaint and motion for preliminary injunction filed against Florida SB 254 adult trans care restrictions, including the ban on nurse practitioner prescribers and the mandated in-person consent forms

Posted on August 1, 2023 by Zinnia Jones

Key takeaways: SB 254 created arbitrary and capricious roadblocks to nearly every trans adult in Florida seeking to continue their prescribed gender-affirming hormone therapy, with new restrictions and bans on the care we can receive from physicians, nurse practitioners, and … Continue reading →

Posted in Dekker v. Weida, Doe v. Ladapo, Endocrinology, Ethics, Florida, Health care, Law, News, Politics, Psychology and psychiatry, SB 254, Surgery, Transgender medicine, Transphobia and prejudice | Tagged , , , , , , , , , , , | Leave a comment

Rapid response: Live coverage of Florida Board of Medicine 28 October 2022 anti-trans rulemaking meeting (raw)

Posted on October 28, 2022 by Zinnia Jones

Previously: CMA against Florida: Catholic Medical Association members Hruz, Van Meter, and Lappert have worked with Alliance Defending Freedom since 2017 to develop a group of anti-trans expert witnesses (September 2022) Catholic Medical Association members wrote a majority of Florida … Continue reading →

Posted in Catholic Church, Endocrinology, Ethics, Florida, Health care, News, Politics and law, Regret and detransition, Replies, Trans youth, Transphobia and prejudice | Tagged , , , , , , , , , , | Leave a comment

Beckman Coulter Access Sensitive Estradiol test, subject of FDA adverse event reports, may give falsely low readings for trans women on oral HRT

Posted on February 28, 2022 by Zinnia Jones

Previously: Put it under your tongue? Typical hormone levels for trans women on HRT, and differing effects of oral and parenteral estradiol (January 2021) HRT for trans women and transfeminine people is intended to lower testosterone levels and raise estrogen … Continue reading →

Posted in Endocrinology, Safety data, Transfeminine | Tagged , , | Leave a comment

What happened, proxalutamide? New antiandrogen for COVID-19 is entangled in clinical data irregularities and human rights violations

Posted on December 1, 2021 by Zinnia Jones

Disclaimer: I am not a medical professional and this is not medical advice. From the outset of the COVID-19 pandemic, there has been interest in a possible relationship between sex hormones and likelihood of infection or severity of disease. Cis … Continue reading →

Posted in Antiandrogens, COVID-19, Endocrinology, Ethics, News | Tagged , , , | Leave a comment

Recent report of potential fertility preservation in an early-transitioning trans girl: A new nuance, but no breakthrough yet

Posted on November 30, 2021 by Zinnia Jones

Disclaimer: I am not a medical professional and this is not medical advice. Previously: Transmasculine adolescent fertility breakthrough: Successful egg retrieval following puberty blockers since Tanner 2 and direct continuation to testosterone (May 2021) In trans adolescents, puberty-blocking GnRH agonists … Continue reading →

Posted in Biology of transition, Endocrinology, Fertility and reproduction, Trans youth, Transfeminine | Tagged , , , , , , | Leave a comment